Downregulation of wild-type β-catenin expression by interleukin 6 in human hepatocarcinoma HepG2 cells: a possible role in the growth-regulatory effects of the cytokine?-Reference-Cited by-同舟云学术

Downregulation of wild-type β-catenin expression by interleukin 6 in human hepatocarcinoma HepG2 cells: a possible role in the growth-regulatory effects of the cytokine?

Published:2001-03 Issue:4 Volume:37 Page:512-519
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Cervello M,Notarbartolo M,Landino M,Cusimano A,Virruso L,Montalto G,D'Alessandro N

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference40 articles.

1. Autocrine generation and requirement of BSF/IL-6 for human multiple myelomas;Kawano;Nature,1988

2. Interleukin-6 (IL-6) functions as an autocrine growth factor in renal cell carcinoma;Miki;FEBS Lett.,1989

3. Expression of the interleukin-6 receptor and interleukin-6 in prostate carcinoma cells;Siegall;Cancer Res.,1990

4. Blocking signalling through the gp130 receptor chain by interleukin-6 and oncostatin M inhibits PC-3 cell growth and sensitizes the tumor cells to VP-16 and CDDP-mediated cytotoxicity;Borsellino;Cancer,1999

5. Synergistic regulatory effect of interleukin 6 and interleukin 1 on the growth and differentiation of human and mouse myeloid leukemic cell lines;Onozaki;Cancer Res.,1989

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-interleukin-6 receptor antibody improves allodynia and cognitive impairment in mice with neuropathic pain following partial sciatic nerve ligation;International Immunopharmacology;2022-11

2. The Urinary Proteomic Profile Implicates Key Regulators for Urologic Chronic Pelvic Pain Syndrome (UCPPS): A MAPP Research Network Study;Molecular & Cellular Proteomics;2022-01

3. The Cell Culture Medium Affects Growth, Phenotype Expression and the Response to Selenium Cytotoxicity in A549 and HepG2 Cells;Antioxidants;2019-05-14

4. Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma;International Journal of Cancer;2018-12-24

5. In vitro antiproliferative and antioxidant effects of urolithin A, the colonic metabolite of ellagic acid, on hepatocellular carcinomas HepG2 cells;Toxicology in Vitro;2015-08